The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/30595
StudyName: Eligibility Metastatic Breast Cancer NCT00875979
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 17.06.2018
License: Creative Commons BY 4.0

----

Description: 
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab; ODM derived from: https://clinicaltrials.gov/show/NCT00875979
